Sherlock Biosciences is a pioneering company based in Watertown, MA, that is revolutionizing the field of molecular diagnostics. By combining the power of CRISPR and synthetic biology, they are developing accurate, rapid, and affordable diagnostic tools for DNA and RNA detection. Their goal is to democratize and decentralize testing, enabling personalized healthcare and making a significant impact on global health.
With a team of experts and founders who are passionate advocates for consumer health, Sherlock Biosciences is committed to disrupting current healthcare paradigms. Their innovative platforms and technologies are designed to provide diagnostic products that empower individuals to easily access answers and take control of their health decisions. Through their groundbreaking approach, they are driving disruption, catalyzing change, and working towards a future where diagnostic tests are accessible to people at the point-of-need.
Generated from the website